Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Antibiotics, such as daptomycin, may control neutropenia, fever, and infection in
patients with cancer.
PURPOSE: This phase II trial is studying how well daptomycin works in treating neutropenia
and fever in patients with cancer.